CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 8-K Event Other events
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,818 shares (to pay taxes)
- 4 Planned sale Chief Medical Officer sold 2,161 shares at $13.64 ($29,476)
- SC TO-I/A Deal Tender Offer Statement by Issuer
- 4 Open-market sale Chief Medical Officer sold 56,333 shares at an average $12.23 ($688,756)
- 144 Insider Sale of Securities
- SC TO-I/A Deal Tender Offer Statement by Issuer
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC TO-I Deal Tender Offer Statement by Issuer
- 8-K Event Shareholder vote results · Other events
- 4 Grant or award Director acquired 9,807 shares (grant or award)
- 4 Grant or award Director acquired 9,807 shares (grant or award)
- 4 Grant or award Director acquired 9,807 shares (grant or award)
- 4 Grant or award Director acquired 9,807 shares (grant or award)
- 4 Grant or award Director acquired 9,807 shares (grant or award)
- 4 Grant or award Director acquired 9,807 shares (grant or award)
Page 2 of 41 · 806 filings